It is known that the transcription factor BRG1 is essential for the survival and maintenance of the self-renewal potential of AML cells (mouse cell lines carrying the cbfβ-myh11 or mll-af9 mutation). The gene discussed is KMT2A; the disease is acute myeloid leukemia.